๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Application of Biomarkers in Neurological Diseases
NCT05881226Biomarkers
Yi Yang
Observational
3,000
Changchun
2023-06-05
Active, closed
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT05869903Obesity, Overweight, Overweight or Obesity
Eli Lilly and Company
Phase 3
3,127
Hefei, Beijing, Chongqing, Shenzhen, Haikou, Harbin, Luoyang Shi, Zhengzhou
2023-06-05
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
AstraZeneca
Phase 1/2
602
Chengdu, Chongqing, Guangzhou, Jinan, Xi'an, Zhengzhou
2023-06-05
Recruiting
The Pathogenesis and Prognostic Factors of Lymphoma
NCT06203652Lymphoma, Hodgkin Lymphoma, Non-hodgkin Lymphoma
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2023-06-05
Recruiting
Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001
NCT06410092Solid Tumor
Sound Biopharmaceuticals Ltd.
Phase 1
44
Beijing, Chongqing, Chengdu
2023-06-05
Recruiting
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
NCT05871762Rectal Neoplasms
Peking Union Medical College Hospital
Observational
3,705
Beijing
2023-06-04
Active, closed
Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control
NCT05894382Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
236
Shanghai
2023-06-03
Active, closed
A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)
NCT05692492Nonalcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd
Phase 2
180
Guangzhou
2023-06-03
Active, closed
Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug
NCT05793307Pompe Disease Infantile-Onset
GeneCradle Inc
Phase 1/2
16
Beijing, Changsha, Hangzhou, Zhengzhou
2023-06-02
Active, closed
A Phase โ…ข Clinical Study of MIL62 in Primary Membranous Nephropathy
NCT05862233Primary Membranous Nephropathy
Beijing Mabworks Biotech Co., Ltd.
Phase 3
150
Beijing
2023-06-02
Recruiting
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
NCT05910398Breast Cancer Invasive
RenJi Hospital
Phase 3
488
Shanghai
2023-06-01
Recruiting
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
NCT06249256Solid Tumor
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
12
Shanghai
2023-06-01
Recruiting
Effects of Propofol on Brain Function in Patients With Parkinson's Disease
NCT05895019PD - Parkinson's Disease
Beijing Tiantan Hospital
Observational
600
Beijing
2023-06-01
Recruiting
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
NCT06035016HER2-positive Breast Cancer, Early-stage Breast Cancer
Peking Union Medical College Hospital
Observational
300
Beijing
2023-06-01
Recruiting
NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors
NCT05881525Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase 1
18
Chongqing
2023-06-01
Active, closed
Effect of IOP Lowering on Progressive HM
NCT05850936High Myopia, Intraocular Pressure
Sun Yat-sen University
Not applicable
152
Guangzhou
2023-06-01
Active, closed
The Advantages and Disadvantages of Linear Anastomat and Tubular Anastomat in Radical Gastrectomy of Distal Gastric Cancer
NCT07080879Gastric Cancer
Xiangya Hospital of Central South University
Not applicable
250
Changsha
2023-06-01
Recruiting
Disitamab Vedotin (RC48-ADC) in Breast Cancer
NCT05851677Breast Cancer
RenJi Hospital
Observational
45
Shanghai
2023-06-01
Recruiting
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs
NCT06423170Unresectable Gallbladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
37
Guangzhou
2023-06-01
Recruiting
A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL
NCT05931263Newly Diagnosed Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase 3
104
Nanjing
2023-06-01
Recruiting
Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer
NCT05876065Advanced Breast Cancer
Wenjin Yin
Not applicable
86
Shanghai
2023-06-01
Recruiting
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
NCT05901428Hormone Receptor Positive HER-2 Negative Breast Cancer
Fudan University
Phase 3
1,736
Shanghai
2023-06-01
Recruiting
Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis
NCT05882708Sepsis, Ivabradine, Hemodynamics, Heart Rate Control
Second Affiliated Hospital of Guangzhou Medical University
Phase 4
172
Guangzhou
2023-06-01
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
NCT06074692Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone
Ruijin Hospital
Phase 2
86
Shanghai
2023-06-01
Recruiting
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
NCT05902416Acute Leukemia, Myelodysplastic Syndromes
Peking University People's Hospital
Observational
120
Beijing
2023-06-01
Recruiting
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
NCT05891093Breast Cancer
Fudan University
Phase 3
766
Beijing, Chongqing, Fuzhou, Guangzhou, Guangdong, Nantong, Yangzhou, Shenyang
2023-06-01
Recruiting
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
NCT05899621Follicular Lymphoma
Ruijin Hospital
Observational
332
Shanghai
2023-06-01
Recruiting
Effects of Digital Therapeutic in Whole Process Management of Lung Cancer
NCT06230445Application of Digital Therapeutic in Lung Cancer Whole Process Management
Sun Yat-sen University
Phase 3
900
Guangzhou
2023-06-01
Recruiting
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
NCT06595966Breast Cancer, Measurable Residual Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
80
Hangzhou
2023-06-01
Active, closed
Retrospective Study of Germ Cell Tumors of the Central Nervous System
NCT05836701Germ Cell Tumor of CNS
Beijing Sanbo Brain Hospital
Observational
500
Beijing
2023-06-01
Active, closed
Health Belief Model-Based Survey on Breast Self-Examination Awareness and Practice Among Community-Dwelling Middle-Aged and Older Women
NCT07149636Breast Neoplasms, Breast Self-Examination, Cancer Screening, Health Belief Model
Peking Union Medical College Hospital
Observational
3,000
Beijing
2023-06-01
Recruiting
A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer
NCT05862064TNBC - Triple-Negative Breast Cancer
Fudan University
Phase 3
606
Shanghai
2023-06-01
Recruiting
Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
NCT05937191Idiopathic Pulmonary Hemosiderosis, Leflunomide
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2
34
Guangzhou
2023-06-01
Active, closed
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
NCT05844150SCLC
Biotheus Inc.
Phase 2
50
Beijing, Changchun, Chongqing, Guangzhou, Hangzhou, Harbin, Hefei, Jinan
2023-06-01
Recruiting
Mechanism Study of Ventilator-Induced Lung Injury in Elderly People.
NCT06367946Ventilator-Induced Lung Injury
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2023-06-01
Recruiting
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
NCT06114225Osteosarcoma
Ruijin Hospital
Phase 2
43
Shanghai
2023-06-01
Recruiting
Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors
NCT06082648Rectal Neoplasms
Huashan Hospital
Not applicable
57
Shanghai
2023-06-01
Recruiting
Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm
NCT06478576Thoracoabdominal Aortic Aneurysm
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
73
Beijing
2023-06-01
Recruiting
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection
NCT06018363Brain Gliomas, High-Grade Gliomas, GBM
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2
25
Suzhou
2023-06-01
Recruiting
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
NCT06295432Non-small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 2
90
Guangzhou, Wuhan, Xi'an, Zhengzhou
2023-06-01
Active, closed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B
NCT07190742Chronic Hepatitis B Virus
Grand Theravac Life Sciences (Nanjing) Co., Ltd.
Phase 2
80
Beijing
2023-06-01
Recruiting
Status of Disease Burden of Lower Urinary Tract Symptoms in Chinese Male Community
NCT06352736Lower Urinary Tract Symptoms
Chinese PLA General Hospital
Observational
12,567
Beijing
2023-06-01
Recruiting
Tocilizumab and Tofacitinib in the Treatment of Vascular Behรงet's Syndrome
NCT05845723Aneurysm, Behcet Syndrome, Vascular Type
Peking Union Medical College Hospital
Phase 2
81
Beijing
2023-06-01
Not yet open
Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients
NCT05894850Artificial Intelligence, Surveillance
Renmin Hospital of Wuhan University
Not applicable
1,644
Wuhan
2023-06-01
Active, closed
MRD in High-risk EBC
NCT06566729Breast Cancer
Shanghai Jiao Tong University School of Medicine
Observational
125
Shanghai
2023-06-01
Recruiting
Magnetocardiography in the Accurate Identification of Myocardial Infarction
NCT05896826Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
Qilu Hospital of Shandong University
Observational
3,841
Jinan
2023-06-01
Recruiting
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
NCT06441110Urinary Bladder Neoplasms, BCG Vaccine, Immunotherapy, Active, Multicenter Study
Fujian Medical University Union Hospital
Phase 3
76
Fuzhou
2023-06-01
Recruiting
Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
NCT05861271Breast Cancer Stage I
Fudan University
Phase 2
1,008
Shanghai
2023-06-01
Recruiting
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
NCT06371482SCLC, Limited Stage
Hebei Medical University Fourth Hospital
Phase 2
58
Shijiazhuang
2023-06-01
Recruiting
A Study of Orelabrutinib Plus R-CHOP in Treatment-naรฏve Patients With Double Expression Diffuse Large B-cell Lymphoma
NCT05933967The First Affiliated Hospital of Nanchang University
Shandong Cancer Hospital and Institute
Phase 2
31
Nanchang, Jinan
2023-06-01
Active, closed
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)
NCT05607550Metastatic Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer, EGFR Exon 20 Mutations
ArriVent BioPharma, Inc.
Phase 3
398
Beijing, Meizhou, Xuhui, Hangzhou, Cangzhou, Shushan, Zhengzhou, Changchun
2023-06-01
Recruiting
Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke
NCT05741905Acute Ischemic Stroke
Yi Yang
Not applicable
100
Changchun
2023-06-01
Recruiting
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
NCT05862285Cancer
Hoffmann-La Roche
Phase 3
100
Wuhan, XI 'an City, Shaanxi Province, Shanghai, Beijing, Changchun, Chengdu, Guangzhou, Hangzhou
2023-06-01
Recruiting
A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT05896800Chronic Obstructive Pulmonary Disease
The First Affiliated Hospital with Nanjing Medical University
Not applicable
24
Nanjing
2023-06-01
Recruiting
JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer
NCT04951947Small-cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
30
Changsha
2023-06-01
Not yet open
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
NCT05802654Early Lung Cancer, Stereotactic Body Radiotherapy
Peking University Third Hospital
Not applicable
100
Beijing
2023-06
Recruiting
Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
NCT05738525End-stage Renal Disease
Chinese PLA General Hospital
Observational
750
Beijing
2023-06
Not yet open
Donors Predisposed by Corneal Collagen Cross-linking in Deep Lamellar Keratoplasty for the Patients With Keratoconus
NCT05905978Keratoconus
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
70
Guangzhou
2023-06
Recruiting
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
NCT05917431Unresectable Hepatocellular Carcinoma, Oligometastatic Disease
Peking University Cancer Hospital & Institute
Phase 2
39
Beijing
2023-06
Recruiting
Consistency of Carotid Doppler Blood Flow and Thermodilution Technique
NCT05944146Cardiac Surgery
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2023-05-31
Recruiting
Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
NCT05729646Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency
Yu jiren
Phase 2
90
Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
2023-05-31
Recruiting
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions
NCT05894863Peripheral Arterial Disease
RenJi Hospital
Not applicable
120
Shanghai
2023-05-31
Active, closed
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566Small Cell Lung Cancer (SCLC)
Amgen
Phase 3
509
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Jiangmen, Shijiazhuang, Harbin
2023-05-31
Recruiting
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
NCT06754345Tumor, PD-L1
The First Affiliated Hospital of Xiamen University
Observational
100
Xiamen
2023-05-30
Recruiting
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
NCT05930210Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus, Wound
Energenesis Biomedical Co., Ltd.
Phase 3
230
2023-05-30
By invitation
A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
NCT06186804cGvHD
Abbisko Therapeutics Co, Ltd
Phase 2
64
Beijing, Chongqing, Fuzhou, Guangzhou, Zhujiang, Wuhan, Hangzhou, Suzhou
2023-05-30
Recruiting
SG1906 for CLDN18.2-Positive Solid Tumors
NCT05857332Locally Advanced Unresectable or Metastatic Solid Tumors
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1
60
Beijing, Xiamen, Guangzhou, Zhengzhou, Shenyang, Taiyuan, Hangzhou
2023-05-30
Recruiting
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
NCT07644897Melanoma, Immune-related Adverse Event, Immune Checkpoint Inhibitor
Sun Yat-sen University
Phase 2
55
Guangzhou, Shenzhen
2023-05-30
Active, closed
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
NCT05715931Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
Yu jiren
Phase 2
30
Hangzhou, Huzhou, Lishui, Ningbo, Taizhou
2023-05-30
Recruiting
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
NCT06737666Diarrhea-predominant Irritable Bowel Syndrome
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 1
60
Beijing
2023-05-29
Recruiting
Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
NCT06403943Adjuvant, Treatment, Tuberculosis
Beijing Chest Hospital
Phase 4
292
Beijing
2023-05-29
Recruiting
68Ga-P3 PET/CT Imaging in Prostate
NCT05940259Neoplasms
Peking University First Hospital
Not applicable
30
Beijing
2023-05-29
Recruiting
Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke
NCT05921682Heat Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
100
Yiwu, Dongyang, Hangzhou, Jinhua, Lanxi
2023-05-28
Recruiting
Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke
NCT05923931Heat Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
126
Guli, Yiwu, Dongyang, Hangzhou, Jinhua, Lanxi
2023-05-28
Recruiting
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
NCT05886114Cognitive Impairment, Alzheimer Disease, Vascular Cognitive Impairment, Dement
Zhejiang University
Not applicable
1,200
Hangzhou
2023-05-28
Active, closed
A Study of MHB036C for Advanced Solid Tumor
NCT06373406Advanced Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
200
Shanghai
2023-05-26
Recruiting
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NCT05866029Osteoporotic Fractures
Peking Union Medical College Hospital
Not applicable
2,478
Beijing, Changchun, Changsha, Changzhou, Chengdu, Dalian, Dongying, Guiyang
2023-05-26
Recruiting
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NCT05662540NK/T-cell Lymphoma
Ruijin Hospital
Not applicable
40
Shanghai
2023-05-26
Active, closed
A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus
NCT05796206Systemic Lupus Erythematosus
Beijing Mabworks Biotech Co., Ltd.
Phase 2
120
Beijing
2023-05-26
Recruiting
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
NCT05859750Pancreatic Cancer
Akeso
Phase 2
78
Beijing, Guangzhou, Wuhan, Jinan, Shanghai, Hangzhou
2023-05-25
Recruiting
Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment
NCT05857800Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Observational
2,000
Shanghai
2023-05-25
Recruiting
Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon ฮฑ-2b Combined With NA.
NCT06746701HBV
Xiangya Hospital of Central South University
Observational
400
Guangzhou, Chenzhou, Hengyang
2023-05-25
Active, closed
A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon Cancer
NCT05890742MSI-H
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
453
Guangzhou
2023-05-25
Recruiting
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
NCT05721404Peritoneal Dialysis
First Affiliated Hospital, Sun Yat-Sen University
Phase 4
194
Guangzhou
2023-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
NCT06697535Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd
Phase 2
35
Changsha
2023-05-24
Recruiting
Dongzong Cardiovascular Bio-imaging Registry Study
NCT06894095Cardiovascular Diseases, Multi-omics, Living Environments, Pulmonary-cardiovascular Imaging
Jinling Hospital, China
Observational
50,000
Nanjing
2023-05-24
Recruiting
Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
NCT05540938Rheumatoid Arthritis
China-Japan Friendship Hospital
Phase 4
340
Beijing
2023-05-23
Active, closed
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
NCT05870917Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2023-05-23
Active, closed
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
NCT05687890Diabetic Kidney Disease, IgA Nephropathy
Biocity Biopharmaceutics Co., Ltd.
Phase 2
255
Hangzhou
2023-05-23
Recruiting
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
NCT05831033Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
16
Shanghai
2023-05-23
Recruiting
Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
NCT05494502Breast Neoplasms, Mastectomy, Nerve Block, Dexmedetomidine
Peking University First Hospital
Not applicable
1,206
Beijing
2023-05-23
Recruiting
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
NCT05942625IgA Nephropathy, Focal Segmental Glomerulosclerosis
Hansoh BioMedical R&D Company
Phase 1
84
Nanjing
2023-05-23
Active, closed
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent ฮฒ-thalassemia.
NCT05860595Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
3
Tianjin
2023-05-23
Recruiting
An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A
NCT05849740Acquired Hemophilia
Institute of Hematology & Blood Diseases Hospital, China
Phase 4
25
Tianjin
2023-05-22
Recruiting
68Ga-P3 PET/CT Imaging in Malignancy
NCT05887687Neoplasms
Peking University First Hospital
Not applicable
350
Beijing
2023-05-20
Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
NCT05895786Myositis
Pfizer
Phase 3
318
Hefei, Beijing, Dongguan, Guangzhou, Cangzhou, Changsha, Nanjing, Nanchang
2023-05-20
Recruiting
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
NCT05877872Nasopharyngeal Carcinoma, De-escaltion Therapy
Sun Yat-sen University
Phase 3
424
Guangzhou
2023-05-20
Recruiting
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
NCT05596344Malignant Tumor, Anxiety, Depression
Henan Cancer Hospital
Observational
200
Zhengzhou
2023-05-20
Recruiting
The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
NCT05857891Acute Respiratory Distress Syndrome
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2023-05-20
Recruiting
Gene Therapy for Diabetic Macular Edema
NCT05916391Diabetic Macular Edema
Frontera Therapeutics
Phase 1
18
Tianjin
2023-05-19
Rows per page Showing 15201–15300 of 19052
Previous 151 152 153 154 155 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=153

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.